Interleukin-17A Antagonist
DBCAT003508Therapeutic category
A DrugBank category of 2 drugs. 2 of them are approved.
- Also known as
- Interleukin-17A Antagonists
What you can answer from here — as of October 03, 2019
Which targets do Interleukin-17A Antagonist share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account